Abonnement à la biblothèque: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publication de 6  numéros par an

ISSN Imprimer: 0743-4863

ISSN En ligne: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Atopic Dermatitis: Drug Delivery Approaches in Disease Management

Volume 32, Numéro 4, 2015, pp. 323-361
DOI: 10.1615/CritRevTherDrugCarrierSyst.2015012114
Get accessGet access

RÉSUMÉ

In this review, we describe the very basic of atopic dermatitis (AD), the established management strategies, and the advances in drug delivery approaches for successful therapeutic outcomes. The multifactorial pathophysiology of AD has given rise to the clinician's paradigm of topical and systemic therapy and potential combinations. However, incomplete remission of skin disorders like AD is a major challenge to be overcome. Recurrence is thought to be due to genetic and immunological etiologies and shortcomings in drug delivery. This difficulty has sparked research in nanocarrier-based delivery approaches as well as molecular biology-inspired stratagems to deal with the immunological imbalance and to address insufficiencies of delivery propositions. In this review, we assess various novel drug delivery strategies in terms of their success and utility. We present a brief compilation and assessment of management modalities to sensitize the readers to therapeutic scenario in AD.

CITÉ PAR
  1. Jeong Ji Heun, Back Seung Keun, An Jong Hun, Lee Nam‐Seob, Kim Do‐Kyung, Na Chun Soo, Jeong Young‐Gil, Han Seung Yun, Topical film prepared with Rhus verniciflua extract‐loaded pullulan hydrogel for atopic dermatitis treatment , Journal of Biomedical Materials Research Part B: Applied Biomaterials, 107, 7, 2019. Crossref

  2. Badihi Amit, Frušić-Zlotkin Marina, Soroka Yoram, Benhamron Sandrine, Tzur Tomer, Nassar Taher, Benita Simon, Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment, Nanomedicine: Nanotechnology, Biology and Medicine, 24, 2020. Crossref

  3. Ariyo Oluwakemi O., Ajayi Abayomi M., Ben-Azu Benneth, Aderibigbe Adegbuyi O., Anti-nociceptive and anti-inflammatory activities of ethanol extract and fractions of Morus mesozygia Stapf (Moraceae) leaves and its underlying mechanisms in rodents, Journal of Ethnopharmacology, 259, 2020. Crossref

  4. Metwally Sara, Ura Daniel P., Krysiak Zuzanna J., Kaniuk Łukasz, Szewczyk Piotr K., Stachewicz Urszula, Electrospun PCL Patches with Controlled Fiber Morphology and Mechanical Performance for Skin Moisturization via Long-Term Release of Hemp Oil for Atopic Dermatitis, Membranes, 11, 1, 2020. Crossref

  5. Kaur Gurjot, Negi Poonam, Kapoor Vijay Kumar, Nutraceuticals in dermal diseases, in Nutraceuticals, 2021. Crossref

  6. Hemrajani Chetna, Negi Poonam, Parashar Arun, Gupta Gaurav, Jha Niraj Kumar, Singh Sachin Kumar, Chellappan Dinesh Kumar, Dua Kamal, Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective, Biomedicine & Pharmacotherapy, 147, 2022. Crossref

  7. Ghaderkhani Jalal, Yousefimashouf Rasoul, Arabestani Mohammadreza, Roshanaei Ghodratollah, Asl Sara Soleimani, Abbasalipourkabir Roghayeh, Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus, Artificial Cells, Nanomedicine, and Biotechnology, 47, 1, 2019. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain